诺诚健华-U
(688428)
| 流通市值：77.29亿 | | | 总市值：508.22亿 |
| 流通股本：2.68亿 | | | 总股本：17.65亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 731,434,172.32 | 381,263,139.35 | 1,009,448,013.44 | 697,748,228.93 |
| 营业收入 | 731,434,172.32 | 381,263,139.35 | 1,009,448,013.44 | 697,748,228.93 |
| 二、营业总成本 | 818,906,369.64 | 383,940,887.34 | 1,463,013,205.36 | 975,965,605.67 |
| 营业成本 | 76,713,340.75 | 36,066,440.09 | 138,441,152.27 | 98,028,598.02 |
| 税金及附加 | 10,873,765.55 | 6,989,137.1 | 15,235,964.22 | 10,737,102.16 |
| 销售费用 | 244,071,738.14 | 114,012,126.98 | 419,960,584.26 | 273,927,859.06 |
| 管理费用 | 83,603,184.09 | 42,762,733.27 | 168,528,403.9 | 125,820,073.29 |
| 研发费用 | 449,697,879.35 | 207,599,189.43 | 814,609,352.61 | 614,983,375.71 |
| 财务费用 | -46,053,538.24 | -23,488,739.53 | -93,762,251.9 | -147,531,402.57 |
| 其中:利息费用 | 27,219,566.97 | 13,518,113.67 | 33,794,672.67 | 20,557,333.16 |
| 其中:利息收入 | 61,982,149.82 | 33,751,558.37 | 171,589,406.1 | 138,559,308.84 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,942,867.43 | 2,560,936.02 | -30,462,084.77 | -29,423,716.12 |
| 加:投资收益 | 20,805,451.46 | 10,544,273.33 | 7,116,535.18 | 3,091,034.65 |
| 资产处置收益 | 3,398.23 | 3,398.23 | - | - |
| 资产减值损失(新) | -141,276.45 | -188,438.83 | -104,960.97 | - |
| 信用减值损失(新) | 146,443.13 | 239,188.28 | -1,495,049.39 | -683,961.47 |
| 其他收益 | 30,829,998.93 | 5,912,441.49 | 27,461,588.87 | 19,951,442.33 |
| 四、营业利润 | -30,885,314.59 | 16,394,050.53 | -451,049,163 | -285,282,577.35 |
| 加:营业外收入 | 301,725.66 | - | 274,521.12 | 47,821.12 |
| 减:营业外支出 | - | - | 1,818,276.13 | 54,408.11 |
| 五、利润总额 | -30,583,588.93 | 16,394,050.53 | -452,592,918.01 | -285,289,164.34 |
| 减:所得税费用 | 5,054,697.2 | 1,918,575.7 | 262,747.31 | 28,419.7 |
| 六、净利润 | -35,638,286.13 | 14,475,474.83 | -452,855,665.32 | -285,317,584.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -35,638,286.13 | 14,475,474.83 | -452,855,665.32 | -285,317,584.04 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -30,091,411.19 | 17,967,628.89 | -440,632,966.49 | -275,409,931.99 |
| 少数股东损益 | -5,546,874.94 | -3,492,154.06 | -12,222,698.83 | -9,907,652.05 |
| 扣除非经常损益后的净利润 | -82,271,316.12 | 1,591,658.29 | -440,220,087.4 | -267,086,382 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.02 | 0.01 | -0.26 | -0.16 |
| (二)稀释每股收益 | -0.02 | 0.01 | -0.26 | -0.16 |
| 八、其他综合收益 | -19,858,058.16 | -6,625,303.26 | 60,761,064.42 | -61,320,760.95 |
| 归属于母公司股东的其他综合收益 | -19,858,058.16 | -6,625,303.26 | 60,761,064.42 | -61,320,760.95 |
| 九、综合收益总额 | -55,496,344.29 | 7,850,171.57 | -392,094,600.9 | -346,638,344.99 |
| 归属于母公司股东的综合收益总额 | -49,949,469.35 | 11,342,325.63 | -379,871,902.07 | -336,730,692.94 |
| 归属于少数股东的综合收益总额 | -5,546,874.94 | -3,492,154.06 | -12,222,698.83 | -9,907,652.05 |
| 公告日期 | 2025-08-20 | 2025-05-14 | 2025-03-28 | 2024-11-12 |
| 审计意见(境内) | | | 标准无保留意见 | |